NCT06048133 2026-01-23Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)Big Ten Cancer Research ConsortiumPhase 2 Recruiting33 enrolled